SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 13(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
July 30, 2004
Date of Report
(Date of earliest event reported)
HUMAN GENOME SCIENCES, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware | 0-022962 | 22-3178468 | |||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
14200 Shady Grove Road, Rockville, Maryland 20850-7464
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code:(301) 309-8504
Item 12. Disclosure of Results of Operations and Financial Condition
On July 30, 2004, Human Genome Sciences, Inc. issued a press release announcing its financial results for the three months and six months periods ended June 30, 2004. A copy of the release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit Description
99.1 Press Release issued July 30, 2004
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HUMAN GENOME SCIENCES, INC. |
Date: July 30, 2004 | By:/s/ Steven C. Mayer | ||
Steven C. Mayer | |||
Executive Vice President and | |||
Chief Financial Officer |